Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS)

NCT02865915 is registered in ClinicalTrials.gov with Millendo Therapeutics US, Inc. as lead sponsor.

NCT NCT02865915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02865915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS)
Lead sponsor
Millendo Therapeutics US, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2016
Completion date
September 30, 2017
Enrollment
55 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovary syndrome (pcos)